close
114th Congress: We're updating with new data as it becomes available.

H.R.4332 - Generic Drug Application Review Fairness Act of 2012

To amend section 505(j) of the Federal Food, Drug, and Cosmetic Act to extend the period for a first applicant, with respect to a generic drug, to obtain tentative approval without forfeiting the 180-day exclusivity period, and for other purposes. view all titles (2)

All Bill Titles

  • Official: To amend section 505(j) of the Federal Food, Drug, and Cosmetic Act to extend the period for a first applicant, with respect to a generic drug, to obtain tentative approval without forfeiting the 180-day exclusivity period, and for other purposes. as introduced.
  • Short: Generic Drug Application Review Fairness Act of 2012 as introduced.

This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.

Latest Actions View All Actions [2]
 
Mar 30, 2012Referred to the Subcommittee on Health.
Mar 29, 2012Referred to the House Committee on Energy and Commerce.

Vote on This Bill

-% Users Support Bill

0 in favor / 0 opposed
 

Send Your Rep a Letter

about this bill Support Oppose Tracking
Track with MyOC